CHEBI:45906 - suramin

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name suramin
ChEBI ID CHEBI:45906
Definition A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:45904, CHEBI:9363
Supplier Information ChemicalBook:CB8906847, eMolecules:731081
Download Molfile XML SDF
more structures >>
Wikipedia License
Suramin is a medication used to treat African sleeping sickness and river blindness. It is the treatment of choice for sleeping sickness without central nervous system involvement. It is given by injection into a vein. Suramin causes a fair number of side effects. Common side effects include nausea, vomiting, diarrhea, headache, skin tingling, and weakness. Sore palms of the hands and soles of the feet, trouble seeing, fever, and abdominal pain may also occur. Severe side effects may include low blood pressure, decreased level of consciousness, kidney problems, and low blood cell levels. It is unclear if it is safe when breastfeeding. Suramin was made at least as early as 1916. It is on the World Health Organization's List of Essential Medicines. In the United States it can be acquired from the Centers for Disease Control (CDC). In regions of the world where the disease is common suramin is provided for free by the World Health Organization (WHO).
Read full article at Wikipedia
Formula C51H40N6O23S6
Net Charge 0
Average Mass 1297.260
Monoisotopic Mass 1296.04691
InChI InChI=1S/C51H40N6O23S6/c1-25-9-11-29(49(60)54-37-13-15-41(83(69,70)71)35-21-33(81(63,64)65)23-43(45(35)37)85(75,76)77)19-39(25)56-47(58)27-5-3-7-31(17-27)52-51(62)53-32-8-4-6-28(18-32)48(59)57-40-20-30(12-10-26(40)2)50(61)55-38-14-16-42(84(72,73)74)36-22-34(82(66,67)68)24-44(46(36)38)86(78,79)80/h3-24H,1-2H3,(H,54,60)(H,55,61)(H,56,58)(H,57,59)(H2,52,53,62)(H,63,64,65)(H,66,67,68)(H,69,70,71)(H,72,73,74)(H,75,76,77)(H,78,79,80)
InChIKey FIAFUQMPZJWCLV-UHFFFAOYSA-N
SMILES C12=C(C=C(C=C1C(=CC=C2NC(C3=CC=C(C(NC(C=4C=CC=C(NC(NC5=CC=CC(C(NC=6C(=CC=C(C(NC=7C8=C(C=C(C=C8C(=CC7)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)=O)C6)C)=O)=C5)=O)C4)=O)=C3)C)=O)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O
Roles Classification
Biological Role(s): ryanodine receptor agonist
A ryanodine receptor modulator which activates the receptor. Ryanodine receptors (RyRs) act as selective ion channels, modulating the release of calcium. Activating the receptors causes the release of calcium, so depleting internal calcium and ultimately preventing further muscle contraction.
GABA-gated chloride channel antagonist

GABA antagonist
A compound that inhibits the action of gamma-aminobutyric acid.
apoptosis inhibitor
Any substance that inhibits the process of apoptosis (programmed cell death) in multi-celled organisms.
purinergic receptor P2 antagonist
An antagonist at purinergic P2 receptors
EC 2.7.11.13 (protein kinase C) inhibitor
An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of protein kinase C (EC 2.7.11.13).
trypanocidal drug
A drug used to treat or prevent infections caused by protozoal organisms belonging to the suborder Trypanosomatida.
Application(s): GABA antagonist
A compound that inhibits the action of gamma-aminobutyric acid.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
angiogenesis inhibitor
An agent and endogenous substances that antagonize or inhibit the development of new blood vessels.
antinematodal drug
A substance used in the treatment or control of nematode infestations.
trypanocidal drug
A drug used to treat or prevent infections caused by protozoal organisms belonging to the suborder Trypanosomatida.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing suramin (CHEBI:45906) has functional parent naphthalene-1,3,5-trisulfonic acid (CHEBI:36334)
suramin (CHEBI:45906) has role angiogenesis inhibitor (CHEBI:48422)
suramin (CHEBI:45906) has role antinematodal drug (CHEBI:35444)
suramin (CHEBI:45906) has role antineoplastic agent (CHEBI:35610)
suramin (CHEBI:45906) has role apoptosis inhibitor (CHEBI:68494)
suramin (CHEBI:45906) has role EC 2.7.11.13 (protein kinase C) inhibitor (CHEBI:37700)
suramin (CHEBI:45906) has role GABA antagonist (CHEBI:65259)
suramin (CHEBI:45906) has role GABA-gated chloride channel antagonist (CHEBI:38999)
suramin (CHEBI:45906) has role purinergic receptor P2 antagonist (CHEBI:91079)
suramin (CHEBI:45906) has role ryanodine receptor agonist (CHEBI:67114)
suramin (CHEBI:45906) has role trypanocidal drug (CHEBI:36335)
suramin (CHEBI:45906) is a naphthalenesulfonic acid (CHEBI:36336)
suramin (CHEBI:45906) is a phenylureas (CHEBI:134043)
suramin (CHEBI:45906) is a secondary carboxamide (CHEBI:140325)
suramin (CHEBI:45906) is conjugate acid of suramin(6−) (CHEBI:180911)
Incoming suramin(6−) (CHEBI:180911) is conjugate base of suramin (CHEBI:45906)
IUPAC Name
8,8'-{carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]}dinaphthalene-1,3,5-trisulfonic acid
Synonyms Sources
8,8'-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFONIC ACID PDBeChem
Belganyl ChemIDplus
Naganol ChemIDplus
Naphuride ChemIDplus
Suramin KEGG COMPOUND
Manual Xrefs Databases
2966 DrugCentral
5168 ChemSpider
C07974 KEGG COMPOUND
DB04786 DrugBank
HMDB0015582 HMDB
LSM-5775 LINCS
Suramin Wikipedia
SVR PDBeChem
View more database links
Registry Numbers Types Sources
145-63-1 CAS Registry Number KEGG COMPOUND
145-63-1 CAS Registry Number ChemIDplus
3230873 Beilstein Registry Number ChemIDplus
8185304 Beilstein Registry Number Beilstein
Citations
Last Modified
15 October 2021